 Phase: Phase IIType: TreatmentStatus: ActiveAge: 18 to 70Sponsor: OtherProtocol IDs: J0997, NA_00029491, NCT01045460Phase: Phase IIType: BiomarkerLaboratory analysis, TreatmentStatus: Approved-not yet activeAge: 18 and overSponsor: NCI, OtherProtocol IDs: 2643.00, NCI-2013-00486, P30CA015704, NCT01807182 